The data were presented at the American Society for Gene and Cell Therapy annual meeting in Salt Lake City...The presentations will be made at the annual meeting of the American Society of Clinical Oncology in Chicago from May 31 through June 4

Baliopharm GmbH, a subsidiary of Baliopharm AG, of Basel, Switzerland, joined the NEU2 Consortium with a project addressing the recombinant manufacturing of an Fc-free bispecific CD20-CD95 antibody construct (Novotarg) with selectivity for activated B cells and efficacy studies in disease models relevant to multiple sclerosis therapy. The two-year project was funded by the German Federal Ministry of Education and Research. Bayer AG, of Leverkusen, Germany, signed an agreement to acquire the

At the annual meeting of the American Psychiatric Association in San Francisco this week, researchers presented new data on one drug that can lift depression within an hour of its administration: the anesthetic drug ketamine. (See BioWorld Today, July 6, 2011.) Researchers from Mount Sinai School of Medicine presented data at the conference comparing ketamine injections to those with midazolam, a benzodiazepine, a benzodiazepine that "can mimic the anesthetic effects of ketamine, but should not

Results were unveiled in an oral presentation at the annual meeting of the American Gastroenterological Association, during the Digestive Disease Week 2013 conference in Orlando, Fla...Sangamo BioSciences Inc., of Richmond, Calif., said data demonstrating the successful application of its in vivo protein replacement platform (IVPRP) to produce therapeutically relevant levels of Factor VIII in a mouse model were presented at the annual meeting of the American Society of Gene and Cell Therapy

At the annual meeting of the American Psychiatric Association in San Francisco this week, researchers presented new data on one drug that can lift depression within an hour of its administration: the anesthetic drug ketamine. (See BioWorld Today, July 6, 2011.) Researchers from Mount Sinai School of Medicine presented data at the conference comparing ketamine injections to those with midazolam, a benzodiazepine, a benzodiazepine that "can mimic the anesthetic effects of ketamine, but should not

Sunovion Pharmaceuticals Inc., of Marlborough, Mass., will present 18 research posters on Latuda (lurasidone HCl), an atypical antipsychotic indicated for the treatment of adult patients with schizophrenia, at the 166th Annual Meeting of the American Psychiatric Association (APA) in San Francisco

Gilead Science Inc.'s oral targeted cancer drug, idelalisib (GS-1101), made a splash last week when the American Society of Clinical Oncology (ASCO) unveiled thousands of abstracts scheduled for presentation at next week's annual meeting in Chicago

At the Annual Meeting of the American Association for Cancer Research in April, a Novartis scientist involved in the clinical trials for autologous engineered T cells for the treatment of leukemia noted that "our product can be improved in real time," and that the manufacturing process is constantly adjusted in response to patient data

The data were presented at the annual meeting of the American Society of Hypertension

Pearl Therapeutics Inc., of Redwood City, Calif., said it will present four posters at the upcoming annual meeting of the American Thoracic Society

Oncothyreon Inc.'s detailed results for its cancer immunotherapy product L-BLP25 (formerly Stimuvax), reported at the meeting of the American Society of Clinical Oncology Annual Meeting in Chicago, failed to comfort nervous investors

Additional edata will be presented at the annual meeting of the American Society of Clinical Oncology in Chicago...Results from both studies will be presented at the annual meeting of the American Society of Clinical Oncology in Chicago

Nuvo Research Inc., of Mississauga, Ontario, said researchers from the Fraunhofer Institute for Cell Therapy and Immunology IZI and Nuvo presented data on its immune-modulating drug candidate, WF10, including its therapeutic impact on signs and symptoms of experimentally induced rheumatoid arthritis in mice at the 100th Annual Meeting of The American Association of Immunologists in Honolulu

Sangamo BioSciences Inc., of Richmond, Calif., said it presented new clinical data, which demonstrated that SB-728-T treatment resulted in a reduction in the HIV reservoir in HIV-infected subjects, at the 16th Annual Meeting of the American Society of Gene and Cell Therapy in Salt Lake City

The American Society of Clinical Oncology (ASCO) released the first of more than 4,700 abstracts late Wednesday in anticipation of its 2013 annual meeting, scheduled to attract more than 30,000 participants to Chicago from May 31 to June 4...The nivolumab findings reinforced promising data about the compound presented at ASCO 2012 and earlier this year at the American Association for Cancer Research annual meeting. (See BioWorld Today, June 4, 2012, and April 15, 2013.) The Street took notice, too

Dallas-based Gradalis offered the interim results at the Annual Meeting of the American Society of Gene and Cell Therapy in Salt Lake City, in an oral presentation titled, "Randomized Phase II Trial of Adjuvant Autologous Tumor Cell Vaccine (FANG) for High Risk III/IV Ovarian Cancer: Preliminary Results

The data were presented at the Association for Research in Vision and Ophthalmology annual meeting in Seattle

The continuance will be presented for shareholder approval at the company's annual meeting of shareholders on May 21

The data were presented at the Association for Research in Vision and Ophthalmology annual meeting in Seattle